Home/Filings/4/0001209191-22-019064
4//SEC Filing

CORASH LAURENCE M 4

Accession 0001209191-22-019064

CIK 0001020214other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 9:57 PM ET

Size

20.6 KB

Accession

0001209191-22-019064

Insider Transaction Report

Form 4
Period: 2022-03-12
CORASH LAURENCE M
DirectorChief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-12+45,0002,117,586 total
  • Sale

    Common Stock

    2022-03-14$5.04/sh16,152$81,4002,101,434 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-03-1245,0000 total
    Common Stock (45,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-03-12+22,7702,124,204 total
  • Sale

    Common Stock

    2022-03-14$5.04/sh5,982$30,1472,126,716 total
  • Sale

    Common Stock

    2022-03-14$5.04/sh8,173$41,1892,116,031 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-03-1216,66733,333 total
    Common Stock (16,667 underlying)
  • Exercise/Conversion

    Common Stock

    2022-03-12+16,6672,132,698 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-03-1222,77023,460 total
    Common Stock (22,770 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
  • [F2]Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.
  • [F3]The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  • [F4]The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022.
  • [F5]Not applicable.
  • [F6]The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.
  • [F7]The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Issuer

CERUS CORP

CIK 0001020214

Entity typeother

Related Parties

1
  • filerCIK 0001193209

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:57 PM ET
Size
20.6 KB